Cancer Health Treatment Update Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including New Variants Plitidepsin, derived from a sea squirt, may be far more potent than remdesivir against the coronavirus. FDA Approves Enhertu for HER2-Positive Stomach Cancer The antibody-drug conjugate improved response rates and survival compared with chemotherapy. Personalized Blood Test Can Detect Colon Cancer Recurrence Sooner Than Scans Tests for circulating tumor DNA can help predict which patients are more likely to relapse. Statins May Protect the Heart From Toxic Effects of Chemotherapy Cholesterol-lowering meds may reduce cardiotoxic chemotherapy side effects in women with early breast cancer. Seven Scientists with Novel Approaches to Fighting Cancer The Damon Runyon Cancer Research Foundation awards $2.8 million to innovative early career scientists. Advertisement How long does COVID-19 immunity last? Long-lived memory immune cells continue to provide protection even after antibody levels drop. More News About COVID-19 For more news about the novel coronavirus and COVID-19, including how it affects people living with cancer, visit our sister site, COVID Health.com. Cancer Health Winter 2021 Check out our latest print edition! Newsfeed Colorectal Cancer Incidence Is a Growing Concern Among Gen-X, Millennials, and Gen-Z NIH Launches Database to Track Neurological Symptoms of COVID-19 Cancer-Related Suicide Declined in the U.S. During the Past Two Decades Coffee Consumption Linked to Lower Prostate Cancer Risk Blog: Food and Drug Administration (FDA) FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer FDA Approves Xpovio for Refractory or Relapsed Multiple Myeloma FDA Approves Margenza for Metastatic HER2-Positive Breast Cancer Newsfeed Colorectal Cancer Incidence Is a Growing Concern Among Gen-X, Millennials, and Gen-Z NIH Launches Database to Track Neurological Symptoms of COVID-19 Cancer-Related Suicide Declined in the U.S. During the Past Two Decades Coffee Consumption Linked to Lower Prostate Cancer Risk Blog: Food and Drug Administration (FDA) FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer FDA Approves Xpovio for Refractory or Relapsed Multiple Myeloma FDA Approves Margenza for Metastatic HER2-Positive Breast Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: